Amicus Therapeutics Announces Third Quarter 2025 Financial Results and Corporate Updates Q3 2025 Total Revenue of $169M, up 17% at CER Positive Q3 2025 GAAP Net Income of $17M Cash Position of $264M, a $33M Increase in Q3 2025 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., Nov. 04, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, today announced financial results for the quarter ended September 30, 2025. “Amicus achieved yet another impressive qu...
Amicus Therapeutics to Present at Upcoming Investor Conferences in November 2025 PRINCETON, N.J., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in November. 2025 UBS Global Healthcare Conference in Palm Beach Gardens, FL on Monday, November 10, 2025, at 2:45 p.m. ETJefferies Global Healthcare Conference 2025 in London, U.K. on Tuesday, November 18, 2025, at 4:30 p.m. GMT A live audio webcast of each presentation can also be accessed via the investors se...
Carpenter Technology Reports First Quarter Fiscal Year 2026 Results Delivered Record Quarterly Operating IncomeExpanded Operating Margins in Specialty Alloys Operations SegmentDemand Accelerating in Aerospace and Defense End-Use Market with Higher Sequential BookingsCompleted Negotiations for Several Aerospace Long-Term Agreements with Significant Value Realization PHILADELPHIA, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal first quarter ended September 30, 2025. For the quarter, the Company...
Amicus Therapeutics to Announce Third Quarter 2025 Financial Results on November 4, 2025 PRINCETON, N.J., Oct. 23, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that the Company will host a conference call and live audio webcast on Tuesday, November 4, 2025, at 8:30 a.m. ET to discuss financial results for the quarter ended September 30, 2025. Participants and investors interested in accessing the call by phone will need to register using the . After registering, all phone participants will receive a dial-in number along with a personal PIN to access the eve...
Carpenter Technology Declares Quarterly Cash Dividend PHILADELPHIA, Oct. 09, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock, payable December 4, 2025, to shareholders of record on October 21, 2025. About Carpenter TechnologyCarpenter Technology Corporation is a recognized leader in high-performance specialty alloy materials and process solutions for critical applications in the aerospace and defense, medical, and other markets. Founded in 1889, Carpenter ...
Carpenter Technology Announces Conference Call and Webcast PHILADELPHIA, Oct. 01, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) plans to host a conference call and webcast on Thursday, October 23, 2025 at 10:00 a.m. ET to discuss the results of operations for the first quarter of fiscal year 2026, ended September 30, 2025. The call and webcast will follow the release of first quarter fiscal 2026 financial results before the market opens on Thursday, October 23, 2025. Conference Call and Webcast Details What: Carpenter Technology First Quarter Fiscal 2026 Confere...
Moody's Ratings (Moody's) upgraded Carpenter Technology Corporation's (Carpenter) Corporate Family Rating (CFR) to Ba2 from Ba3, its Probability of Default Rating (PDR) to Ba2-PD from Ba3-PD and the rating on its senior unsecured notes to Ba3 from B1. Carpenter's rating outlook remains positive and...
A director at Kingsway Financial Services Inc sold 68,000 shares at 14.449USD and the significance rating of the trade was 67/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last t...
Carpenter Technology Announces GICS Aerospace & Defense Sector Reclassification PHILADELPHIA, Sept. 17, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) today confirmed that its Global Industry Classification Standard (GICS) designation, as determined by MSCI Inc. and S&P Dow Jones Indices, has been reclassified to 20101010 – Aerospace & Defense, effective September 30, 2025. “While we remain focused on the execution of our strategy to drive long-term value, we believe this update will enhance our visibility with sector-focused investors and support a valuation that ...
New 4-Year Data for Pombiliti® (cipaglucosidase alfa-atga) + Opfolda® (miglustat) Presented at ICIEM Long-Term Data Adds to the Growing Body of Evidence Supporting the Compelling Clinical Profile of Pombiliti® + Opfolda® PRINCETON, N.J., Sept. 08, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), today announced the presentation of new 4-year muscle function, muscle strength and biomarker endpoints from the PROPEL open-label extension (OLE) study of cipaglucosidase alfa-atga + miglustat (cipa+mig) in adults with late-onset Pompe disease (LOPD) at the International Congress of Inborn Errors of M...
Amicus Therapeutics to Present at Upcoming Investor Conferences in September 2025 PRINCETON, N.J., Aug. 29, 2025 (GLOBE NEWSWIRE) -- Amicus Therapeutics (Nasdaq: FOLD) today announced that management will participate in upcoming presentations at the following investor conferences in September. Cantor Global Healthcare Conference 2025 in New York, NY, on Wednesday, September 3, 2025, at 10:20 a.m. ETMorgan Stanley 23rd Annual Global Healthcare Conference 2025 in New York, NY on Tuesday, September 9, 2025, at 3:20 p.m. ET A live audio webcast of each presentation can also be accessed via ...
Two Directors at Carpenter Technology Corp sold after exercising options/sold 24,691 shares at between 244.545USD and 244.992USD. The significance rating of the trade was 68/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trade...
Carpenter Technology Declares Quarterly Cash Dividend PHILADELPHIA, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share of common stock, payable September 4, 2025, to shareholders of record on August 26, 2025. About Carpenter Technology Carpenter Technology Corporation is a recognized leader in high-performance specialty alloy materials and process solutions for critical applications in the aerospace and defense, medical, and other markets. Founded in 1889, Carpente...
Carpenter Technology’s Board of Directors Elects Tony Thene as Chairman and CEO PHILADELPHIA, Aug. 13, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced the execution of succession plans for the Board of Directors. Carpenter Technology’s Board of Directors has unanimously elected Tony R. Thene, current President and Chief Executive Officer, to assume the additional duties of Chairman of the Board, effective October 7, 2025, immediately before the commencement of the 2025 Annual Stockholders Meeting. For the last 10 years, Mr. Thene ha...
Carpenter Technology Reports Fourth Quarter and Fiscal Year 2025 Results Delivered Record Quarterly Operating Income in Fourth Quarter Generated Record Adjusted Free Cash Flow in Fourth Quarter Completed Most Profitable Year in Company History Fiscal Year 2026 Outlook 26% to 33% Higher Than Record Fiscal Year 2025 PHILADELPHIA, July 31, 2025 (GLOBE NEWSWIRE) -- Carpenter Technology Corporation (NYSE: CRS) (the “Company”) today announced financial results for the fiscal fourth quarter and year ended June 30, 2025. For the quarter, the Company reported operating income of $151.4 million...
Amicus Therapeutics Announces Second Quarter 2025 Financial Results and Corporate Updates Q2 2025 Total Revenue of $154.7M, up 18% at CER Galafold® Q2 Revenue of $128.9M, up 12% at CER Pombiliti® + Opfolda® Q2 Revenue of $25.8M, up 58% at CER Reiterating 2025 Financial Guidance including GAAP Profitability During H2 2025 Conference Call and Webcast Today at 8:30 a.m. ET PRINCETON, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: FOLD), a patient-dedicated global biotechnology company focused on developing and commercializing novel medicines for rare diseases, tod...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.